The second-quarter 2024 reporting cycle of the Medical sector is about to pick up pace this week. The sector mainly comprises pharma/biotech and medical device companies.The earnings season for the drug and biotech sector kicked off last week when bellwether Johnson & Johnson reported strong second-quarter results, beating estimates for earnings and sales.Swiss pharma giant Novartis AG also reported better-than-expected second-quarter results. Consequently, Novartis increased its operating income growth gui ...